CHDH Promotes Breast Cancer Metastasis Relying on IL17RB / CREB1 Signalling Activation
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yifei Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Precision Medicine Laboratory for Chronic Non-Communicable Diseases, Institute of Precision Medicine, Jining Medical University, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclic AMP Response Element-Binding Protein, Signal Transduction, Receptors, Interleukin-17. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lin He's New Medicine and Clinical Translation Academician Workstation Research Fund, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The involvement of Choline Dehydrogenase (CHDH) in metabolic disorders and tumour progression has garnered significant scholarly interest. However, the specific role of CHDH in the metastasis and progression of breast cancer (BC) has been less thoroughly investigated. Our research indicates that CHDH protein expression is markedly elevated in breast cancer tissues compared to normal tissues, and this expression is positively correlated with the tumour node metastasis (TNM) stage of breast cancer. Furthermore, CHDH levels were found to be significantly higher in breast cancer cell lines relative to normal breast cells. The silencing of CHDH expression resulted in a reduction of breast cancer cell migration, while the overexpression of CHDH facilitated increased migration and tumour metastasis in vivo. Investigations into the underlying mechanisms revealed that CHDH influences the expression of IL17RB and activates Cyclic‐AMP Response Element‐Binding Protein (CREB), thereby mediating breast cancer metastasis. The application of an IL17RB antibody and the CREB inhibitor 666‐15 effectively abolished CHDH‐mediated migration of breast cancer cells in vitro. These findings suggest that CHDH plays a critical role in promoting breast cancer metastasis, potentially offering new targets and strategies for the treatment of metastatic breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Precision Medicine Laboratory for Chronic Non-Communicable Diseases, Institute of Precision Medicine, Jining Medical University, Jining, China.
- Department of Breast Surgery, Dalian Women and Children's Medical Group, Dalian, China.
- College of Clinical Medicine, Jining Medical University, Jining, China.
- Henan Key Laboratory of Immunology and Targeted Drugs, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
ORCID-Profile: Wenzhi Shen
Förderung
- Lin He's New Medicine and Clinical Translation Academician Workstation Research Fund
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Jining Medical University High-level Research Project Cultivation Programme
- NSFC Cultivation Project of Jining Medical University
Zitieren
APA
Li, Y., Liu, Y., Yang, X., Shen, X., Liu, Z., Ma, Y., Zhan, Y., Jiang, X., Liang, C., Zhang, X., Liu, H., & Shen, W. (2025). CHDH Promotes Breast Cancer Metastasis Relying on IL17RB / CREB1 Signalling Activation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70792
Vancouver
Li Y, Liu Y, Yang X, Shen X, Liu Z, Ma Y, et al. CHDH Promotes Breast Cancer Metastasis Relying on IL17RB / CREB1 Signalling Activation. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70792
BibTeX
@article{Li2025,
author = {Li, Yifei and Liu, Yipeng and Yang, Xiaowen and Shen, Xinzhuang and Liu, Zongjun and Ma, Yuqiu and Zhan, Yiting and Jiang, Xinyu and Liang, Chengjin and Zhang, Xiaoyuan and Liu, Huan and Shen, Wenzhi},
title = {CHDH Promotes Breast Cancer Metastasis Relying on IL17RB / CREB1 Signalling Activation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70792}
}
EUVIMED